HUT73762A - Gpharmaceutical compositions containing von willebrand factor (vwf) combined with antitrombotica and fibrinolytica - Google Patents

Gpharmaceutical compositions containing von willebrand factor (vwf) combined with antitrombotica and fibrinolytica

Info

Publication number
HUT73762A
HUT73762A HU9503031A HU9503031A HUT73762A HU T73762 A HUT73762 A HU T73762A HU 9503031 A HU9503031 A HU 9503031A HU 9503031 A HU9503031 A HU 9503031A HU T73762 A HUT73762 A HU T73762A
Authority
HU
Hungary
Prior art keywords
gpharmaceutical
antitrombotica
fibrinolytica
vwf
combined
Prior art date
Application number
HU9503031A
Other languages
English (en)
Other versions
HU219595B (hu
HU9503031D0 (en
Inventor
Gerhard Dickneite
Martin Reers
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of HU9503031D0 publication Critical patent/HU9503031D0/hu
Publication of HUT73762A publication Critical patent/HUT73762A/hu
Publication of HU219595B publication Critical patent/HU219595B/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/37Factors VIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU9503031A 1994-10-20 1995-10-20 Von Willebrand-faktort tartalmazó koncentrátumok alkalmazása trombózis elleni szerek és/vagy fibrinotikus szerek okozta vérzésnél antidotumként ható szer előállítására HU219595B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4437544A DE4437544A1 (de) 1994-10-20 1994-10-20 Einsatz von vWF-enthaltenden Konzentraten als Kombinationstherapie bei Therapie mit Antithrombotika und Fibrinolytika

Publications (3)

Publication Number Publication Date
HU9503031D0 HU9503031D0 (en) 1995-12-28
HUT73762A true HUT73762A (en) 1996-09-30
HU219595B HU219595B (hu) 2001-05-28

Family

ID=6531287

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9503031A HU219595B (hu) 1994-10-20 1995-10-20 Von Willebrand-faktort tartalmazó koncentrátumok alkalmazása trombózis elleni szerek és/vagy fibrinotikus szerek okozta vérzésnél antidotumként ható szer előállítására

Country Status (20)

Country Link
US (1) US5571784A (hu)
EP (1) EP0713881A3 (hu)
JP (1) JPH08208504A (hu)
KR (1) KR960013383A (hu)
CN (1) CN1128168A (hu)
AU (1) AU708670B2 (hu)
CA (1) CA2160975A1 (hu)
CZ (1) CZ287878B6 (hu)
DE (1) DE4437544A1 (hu)
FI (1) FI954964A (hu)
HR (1) HRP950525A2 (hu)
HU (1) HU219595B (hu)
IL (1) IL115652A (hu)
NO (1) NO954175L (hu)
NZ (1) NZ280274A (hu)
PL (1) PL183182B1 (hu)
SK (1) SK129695A3 (hu)
TW (1) TW398977B (hu)
UY (1) UY24063A1 (hu)
ZA (1) ZA958838B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5772629A (en) * 1995-10-23 1998-06-30 Localmed, Inc. Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
AT405485B (de) * 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT409335B (de) * 1998-11-10 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen
US6794412B1 (en) * 1999-03-11 2004-09-21 Bristol-Myers Squibb Pharma Company Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
EP1148063A1 (de) * 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
JP2003284570A (ja) 2001-04-25 2003-10-07 Chemo Sero Therapeut Res Inst フォンビルブラント因子(vWF)切断酵素
DE102008032361A1 (de) * 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
EP2536753B1 (en) * 2010-02-16 2017-12-20 Novo Nordisk A/S Factor viii molecules with reduced vwf binding
ES2657291T3 (es) 2013-04-22 2018-03-02 Csl Ltd. Un complejo covalente de factor de von Willebrand y factor VIII asociado por un puente disulfuro
TWI580423B (zh) * 2013-12-24 2017-05-01 財團法人工業技術研究院 緩解或治療痛風之醫藥組合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198349A (en) * 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
US5200510A (en) * 1987-06-16 1993-04-06 Zymogenetics, Inc. Method for purifying factor viii:c, von willebrand factor and complexes thereof
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
FR2619314B1 (fr) * 1987-08-11 1990-06-15 Transgene Sa Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant
US5204323B1 (en) 1988-10-06 1995-07-18 Ciba Geigy Corp Hirudin antidotal compositions and methods
GB8823480D0 (en) 1988-10-06 1988-11-16 Ciba Geigy Ag Antidote
FR2673632A1 (fr) * 1991-03-08 1992-09-11 Lille Transfusion Sanguine Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique.
DE4115453A1 (de) 1991-05-11 1992-11-12 Knoll Ag Neue wirkstoffkombination
US5366869A (en) * 1991-11-08 1994-11-22 Sheldon Goldstein Multiple coagulation test device and method
DE4203965A1 (de) * 1992-02-11 1993-08-12 Max Planck Gesellschaft Antidot fuer hirudin und synthetische thrombininhibitoren
WO1994025582A1 (en) * 1993-04-23 1994-11-10 Bio-Technology General Corp. Method of enhancing thrombolysis

Also Published As

Publication number Publication date
CZ287878B6 (cs) 2001-03-14
CA2160975A1 (en) 1996-04-21
NZ280274A (en) 1997-01-29
IL115652A (en) 2000-08-31
UY24063A1 (es) 1995-10-24
PL183182B1 (pl) 2002-06-28
FI954964A (fi) 1996-04-21
HU219595B (hu) 2001-05-28
AU3430495A (en) 1996-05-02
DE4437544A1 (de) 1996-04-25
US5571784A (en) 1996-11-05
PL311031A1 (en) 1996-04-29
ZA958838B (en) 1996-05-13
TW398977B (en) 2000-07-21
EP0713881A2 (de) 1996-05-29
NO954175D0 (no) 1995-10-19
CZ271995A3 (en) 1996-05-15
CN1128168A (zh) 1996-08-07
JPH08208504A (ja) 1996-08-13
EP0713881A3 (de) 1996-08-21
HRP950525A2 (en) 1997-04-30
SK129695A3 (en) 1996-10-02
FI954964A0 (fi) 1995-10-18
NO954175L (no) 1996-04-22
HU9503031D0 (en) 1995-12-28
KR960013383A (ko) 1996-05-22
AU708670B2 (en) 1999-08-12
IL115652A0 (en) 1996-01-19

Similar Documents

Publication Publication Date Title
ZA911936B (en) Bleach catalysts and compositions containing same
IL106891A (en) ENR-NR composition
EP0478971A3 (en) Dielectric composition containing cordierite and glass
GB9312529D0 (en) Chipping-resistant composition
IL107167A0 (en) compositions containing relaxin
GB9203474D0 (en) Novel composition
HUT73762A (en) Gpharmaceutical compositions containing von willebrand factor (vwf) combined with antitrombotica and fibrinolytica
EP0273646A3 (en) Polyester composition
GB8921710D0 (en) Ibuprofen triturates and topical compositions containing same
EP0231606A3 (en) Polyester composition
EP0197789A3 (en) Polyester composition
HK172596A (en) Novel polycationic compound and bleach composition containing the same
HUT64389A (en) Bleachnig composition containing peroxide
IL116015A0 (en) Iminooxymethyleneanilides thdir preparation and compositions containing them
EP0214112A3 (en) Polyester compositions containing phthalimidoesters
IL112564A0 (en) 1-beta-methyl-carbapenems and compositions containing them
GB2271929B (en) Compositions containing Tarchonanthus camphoratus
HU9402155D0 (en) Azin-derivatives and insekticidal composition containing them
GB2272222B (en) Command-curable composition
GB9313064D0 (en) Fibre treatment materials and compositions containing them
EP0284426A3 (en) Polyethylene teraphthalate and uses thereof
GB9205194D0 (en) Novel composition
GB9314512D0 (en) Composition and use
GB2271999B (en) Novel composition
GB9316218D0 (en) Novel composition

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee